A

Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy

Clinical Transplantation, vol. 39, pp. e70346

Abstract

BACKGROUND: Allogeneic hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT) have evolved into successful, curative treatments for many severe congenital and acquired diseases. Both use medical products of human origin and should therefore have overarching regulatory frameworks. Both require critical decisions about donor selection, donor/recipient matching, immunosuppression, and long-term care, all tasks best performed by a trained, highly specialized multidisciplinary team. Both need committed institutions and governmental support for their success. Whereas the main barrier for performing SOT is the lack of suitable organs, access to a transplant center is the main limitation for HCT, which remains a highly specialized, complex, resource-intensive, and costly medical procedure. METHODS AND RESULTS: Here, we describe the main indications for HCT and SOT, their similarities and differences regarding donor selection, treatment prior to transplant, intensity and duration of immunosuppression after transplantation, their main complications, and consequences of donation for living donors. CONCLUSIONS: Strategies to improve worldwide access to HCT and SOT are discussed, as well as future developments in this highly innovative field of medicine.

Authors 14

  1. University of Minnesota

    Affiliation as printed

    University of Minnesota Medical School Minneapolis USA

  2. University of London · St George's Hospital · St George's, University of London

    Affiliation as printed

    Infection and Immunity Group, City St George's, Department of Haematology St George's University Hospitals, University of London London UK

  3. Lydia Foeken Aachen

    World Marrow Donor Association

    Affiliation as printed

    WMDA (World Marrow Donor Association) Leiden the Netherlands

  4. Medical University of Vienna

    Affiliation as printed

    Department of Transfusion Medicine and Cell Therapy Medical University Vienna Vienna Austria

  5. Nova Scotia Health Authority

    Affiliation as printed

    Divsion of Nephrology, Department of Medicine Nova Scotia Health; Kidney Research Institute Nova Scotia Nova Scotia Canada

  6. Baylor University Medical Center · Baylor Scott & White Health

    Affiliation as printed

    Kidney Transplant, Baylor Dallas Scott and White Health Dallas USA

  7. Weill Cornell Medicine

    Affiliation as printed

    Department of Medicine Weill Cornell Medical College New York USA

  8. Hospital Samaritano de São Paulo · Universidade Federal de São Paulo

    Affiliation as printed

    Hospital Samaritano & Pediatric Oncology Institute ‐ Graacc – Unifesp Sao Paulo Brazil

  9. Cleveland Clinic

    Affiliation as printed

    Department of Pulmonary Medicine Cleveland Clinic Cleveland Ohio USA

  10. Aichi Medical University · The Japanese Data Center for Hematopoietic Cell Transplantation

    Affiliation as printed

    Department of Registry Science for Transplant and Cellular Therapy Aichi Medical University School of Medicine Aichi Japan

    Japanese Data Center For Hematopoietic Cell Transplantation Aichi Japan

  11. Deutsche Knochenmarkspenderdatei

    Affiliation as printed

    DKMS Group Tübingen Germany

  12. University of Minnesota

    Affiliation as printed

    University of Minnesota Medical School Minneapolis USA

  13. Medical University of Vienna

    Affiliation as printed

    Department of General Surgery, Division of Transplantation Medical University Vienna Vienna Austria

  14. University of Minnesota

    Affiliation as printed

    University of Minnesota Medical School Minneapolis USA

Cited by 1 stored of 1

1 result

No patents citing this paper on Lens.org (checked 2026-10-11).

References 152